Global Manufacturing Execution System in Life Sciences Market Size Study & Forecast, By Solution Type By Deployment, By End-user (Pharmaceutical and Biotechnology Companies, Medical Device Companies, Others ) and Regional Analysis, 2023-2030

Description

List of Tables

Global Manufacturing Execution System in Life Sciences Market is valued at approximately USD 2.47 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 12.20% over the forecast period 2023-2030. A Manufacturing Execution System (MES) in life sciences refers to a software-based solution designed to manage and control the manufacturing processes within the pharmaceutical, biotechnology, and medical device industries. MES facilitates the real-time monitoring, tracking, and execution of manufacturing operations, from raw material preparation to finished product packaging. The increasing prominence of the biopharmaceutical sector, rising technological advancements, and the rise in adoption of Pharma 4.0 stand out as key drivers fueling the demand for Manufacturing Execution Systems (MES) within the life sciences sector. The pharmaceutical industry embracing digital transformation, the push for Pharma 4.0, and the adoption of MES in the life sciences market are on the rise. Pharma 4.0 initiatives aim to bolster connectivity, productivity, compliance, and information management, enabling more effective solutions to industry challenges.

The increasing digitization within the pharmaceutical industry is driving the demand for Pharma 4.0, a significant factor contributing to the expansion of the manufacturing execution system market in the life sciences sector. Pharma 4.0 facilitates heightened connectivity and productivity while streamlining compliance efforts and enabling swift response to emerging issues through enhanced production information management. This model revolutionizes manufacturing processes by fostering more human-centric workflows and connecting workers more effectively. The International Society for Pharmaceutical Engineering (ISPE) and its members are actively developing a roadmap to introduce Pharma 4.0, aiming to empower organizations to harness the full potential of digitalization for faster therapeutic innovations and improved production processes, ultimately benefiting patients. Key stakeholders within the Pharma 4.0 ecosystem are collaborating to accelerate its adoption. For example, in March 2021, Lonza and NNIT announced a strategic partnership aimed at expediting MES projects. This collaboration integrates Lonza's MODA Platform with NNIT's Accelerated Implementation Methodology, providing organizations with a comprehensive Pharma 4.0 solution and facilitating the realization of their digitalization goals at an accelerated pace. Consequently, the increasing adoption of Pharma 4.0 drives the growth of the Manufacturing Execution System Market in The Life Sciences Industry. In addition, the globalization of the life sciences industry and stringent regulatory requirements for biological development are creating new opportunities for market growth. However, the high implementation cost and data security and privacy concerns stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Manufacturing Execution System in Life Sciences Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to technological advancements and the increasing digitization of manufacturing processes within the pharmaceutical industry are key factors propelling market growth in North America. Furthermore, the market benefits from the presence of influential industry players like Emerson Electric Co. and Rockwell Automation, which contribute significantly to streamlining healthcare manufacturing processes. Additionally, the adoption of integrated laboratory automation solutions presents promising growth avenues for MES providers. For instance, Automata's plans to expand its services in the U.S. in February 2023 exemplify the market's expanding opportunities. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as the rising biotechnology industry, rising number of clinical trials, and rising government support for the life science industry in the region.

Major market players included in this report are:

Korber AG
ABB Laboratories
MasterControl Solutions, Inc.
AVEVA Group Limited
Cognizant Technology Solutions Corporation
Rockwell Automation
Nagarro, Inc.
Siemens AG
Emerson Electric Co.
iBase-t, Inc.

Recent Developments in the Market:

In January 2024, CGI Inc. and Korber AG joined hands to provide an integrated solution tailored to optimize production processes for pharmaceutical and life sciences firms. By merging CGI's end-to-end Solution Types with Korber's Werum PAS-X MES Suite, the partnership endeavours to enhance accuracy, efficiency, and safety throughout the pharmaceutical product development cycle. Additionally, clients gain access to real-time data, empowering them to make informed decisions and elevate overall operational performance.
In February 2023, AVEVA Group Limited, a leading industrial software provider, unveiled its latest offering: the AVEVA Manufacturing Execution System. This updated release is designed to streamline the deployment of multi-site MES solutions while mitigating associated costs and complexities. With its enhanced version, AVEVA MES facilitates quicker and more efficient adoption of industry best practices, ultimately driving operational efficiency and sustainability improvements.

Global Manufacturing Execution System in Life Sciences Market Report Scope:

Historical Data - 2020 - 2021
Base Year for Estimation - 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Solution Type, Deployment, End-user, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Solution Type:

Software
Services

By Deployment:

On-Premise
Cloud/Web-Based
Hybrid

By End-user:

Pharmaceutical and Biotechnology Companies
Medical Device Companies
Others (CDMOs, CROs, etc.)

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1.Executive Summary

1.1.Market Snapshot
1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1.Manufacturing Execution System in Life Sciences Market, by Region, 2020-2030 (USD Billion)
- 1.2.2.Manufacturing Execution System in Life Sciences Market, by Solution Type, 2020-2030 (USD Billion)
- 1.2.3.Manufacturing Execution System in Life Sciences Market, by Deployment, 2020-2030 (USD Billion)
- 1.2.4.Manufacturing Execution System in Life Sciences Market, by End-user, 2020-2030 (USD Billion)
1.3.Key Trends
1.4.Estimation Methodology
1.5.Research Assumption

Chapter 2.Global Manufacturing Execution System in Life Sciences Market Definition and Scope

2.1.Objective of the Study
2.2.Market Definition & Scope
- 2.2.1.Industry Evolution
- 2.2.2.Scope of the Study
2.3.Years Considered for the Study
2.4.Currency Conversion Rates

Chapter 3.Global Manufacturing Execution System in Life Sciences Market Dynamics

3.1.Manufacturing Execution System in Life Sciences Market Impact Analysis (2020-2030)
- 3.1.1.Market Drivers
  - 3.1.1.1.Increasing Prominence of Biopharmaceutical Sector
  - 3.1.1.2.Rising Technological Advancements
  - 3.1.1.3.Rise in Adoption of Pharma 4.0
- 3.1.2.Market Challenges
  - 3.1.2.1.High Implementation Cost
  - 3.1.2.2.Data Security and Privacy Concerns
- 3.1.3.Market Opportunities
  - 3.1.3.1.Globalization of Life Sciences Industry
  - 3.1.3.2.Stringent Regulatory Requirements for Biologicals Development

Chapter 4.Global Manufacturing Execution System in Life Sciences Market Industry Analysis

4.1.Porter's 5 Force Model
- 4.1.1.Bargaining Power of Suppliers
- 4.1.2.Bargaining Power of Buyers
- 4.1.3.Threat of New Entrants
- 4.1.4.Threat of Substitutes
- 4.1.5.Competitive Rivalry
4.2.Porter's 5 Force Impact Analysis
4.3.PEST Analysis
- 4.3.1.Political
- 4.3.2.Economical
- 4.3.3.Social
- 4.3.4.Technological
- 4.3.5.Environmental
- 4.3.6.Legal
4.4.Top investment opportunity
4.5.Top winning strategies
4.6.COVID-19 Impact Analysis
4.7.Disruptive Trends
4.8.Industry Expert Perspective
4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Manufacturing Execution System in Life Sciences Market, by Solution Type

5.1.Market Snapshot
5.2.Global Manufacturing Execution System in Life Sciences Market by Solution Type, Performance - Potential Analysis
5.3.Global Manufacturing Execution System in Life Sciences Market Estimates & Forecasts by Solution Type 2020-2030 (USD Billion)
5.4.Manufacturing Execution System in Life Sciences Market, Sub Segment Analysis
- 5.4.1. Software
- 5.4.2.Services

Chapter 6.Global Manufacturing Execution System in Life Sciences Market, by Deployment

6.1.Market Snapshot
6.2.Global Manufacturing Execution System in Life Sciences Market by Deployment, Performance - Potential Analysis
6.3.Global Manufacturing Execution System in Life Sciences Market Estimates & Forecasts by Deployment 2020-2030 (USD Billion)
6.4.Manufacturing Execution System in Life Sciences Market, Sub Segment Analysis
- 6.4.1. On-Premise
- 6.4.2.Cloud/Web-Based
- 6.4.3.Hybrid

Chapter 7.Global Manufacturing Execution System in Life Sciences Market, by End-user

7.1.Market Snapshot
7.2.Global Manufacturing Execution System in Life Sciences Market by End-user, Performance - Potential Analysis
7.3.Global Manufacturing Execution System in Life Sciences Market Estimates & Forecasts by End-user 2020-2030 (USD Billion)
7.4.Manufacturing Execution System in Life Sciences Market, Sub Segment Analysis
- 7.4.1. Pharmaceutical and Biotechnology Companies
- 7.4.2.Medical Device Companies
- 7.4.3.Others (CDMOs, CROs, etc.)

Chapter 8.Global Manufacturing Execution System in Life Sciences Market, Regional Analysis

8.1.Top Leading Countries
8.2.Top Emerging Countries
8.3.Manufacturing Execution System in Life Sciences Market, Regional Market Snapshot
8.4.North America Manufacturing Execution System in Life Sciences Market
- 8.4.1.U.S. Manufacturing Execution System in Life Sciences Market
  - 8.4.1.1.Solution Type breakdown estimates & forecasts, 2020-2030
  - 8.4.1.2.Deployment breakdown estimates & forecasts, 2020-2030
  - 8.4.1.3.End-user breakdown estimates & forecasts, 2020-2030
- 8.4.2.Canada Manufacturing Execution System in Life Sciences Market
8.5.Europe Manufacturing Execution System in Life Sciences Market Snapshot
- 8.5.1.U.K. Manufacturing Execution System in Life Sciences Market
- 8.5.2.Germany Manufacturing Execution System in Life Sciences Market
- 8.5.3.France Manufacturing Execution System in Life Sciences Market
- 8.5.4.Spain Manufacturing Execution System in Life Sciences Market
- 8.5.5.Italy Manufacturing Execution System in Life Sciences Market
- 8.5.6.Rest of Europe Manufacturing Execution System in Life Sciences Market
8.6.Asia-Pacific Manufacturing Execution System in Life Sciences Market Snapshot
- 8.6.1.China Manufacturing Execution System in Life Sciences Market
- 8.6.2.India Manufacturing Execution System in Life Sciences Market
- 8.6.3.Japan Manufacturing Execution System in Life Sciences Market
- 8.6.4.Australia Manufacturing Execution System in Life Sciences Market
- 8.6.5.South Korea Manufacturing Execution System in Life Sciences Market
- 8.6.6.Rest of Asia Pacific Manufacturing Execution System in Life Sciences Market
8.7.Latin America Manufacturing Execution System in Life Sciences Market Snapshot
- 8.7.1.Brazil Manufacturing Execution System in Life Sciences Market
- 8.7.2.Mexico Manufacturing Execution System in Life Sciences Market
8.8.Middle East & Africa Manufacturing Execution System in Life Sciences Market
- 8.8.1.Saudi Arabia Manufacturing Execution System in Life Sciences Market
- 8.8.2.South Africa Manufacturing Execution System in Life Sciences Market
- 8.8.3.Rest of Middle East & Africa Manufacturing Execution System in Life Sciences Market

Chapter 9.Competitive Intelligence

9.1.Key Company SWOT Analysis
9.2.Top Market Strategies
9.3.Company Profiles
- 9.3.1. Korber AG
  - 9.3.1.1.Key Information
  - 9.3.1.2.Overview
  - 9.3.1.3.Financial (Subject to Data Availability)
  - 9.3.1.4.Product Summary
  - 9.3.1.5.Recent Developments
- 9.3.2. ABB Laboratories
- 9.3.3.MasterControl Solutions, Inc.
- 9.3.4.AVEVA Group Limited
- 9.3.5.Cognizant Technology Solutions Corporation
- 9.3.6.Rockwell Automation
- 9.3.7.Nagarro, Inc
- 9.3.8.Siemens AG
- 9.3.9.Emerson Electric Co.
- 9.3.10.iBase-t, Inc.

Chapter 10.Research Process

10.1.Research Process
- 10.1.1.Data Mining
- 10.1.2.Analysis
- 10.1.3.Market Estimation
- 10.1.4.Validation
- 10.1.5.Publishing
10.2.Research Attributes
10.3.Research Assumption

LIST OF TABLES

TABLE 1.Global Manufacturing Execution System in Life Sciences Market, report scope
TABLE 2.Global Manufacturing Execution System in Life Sciences Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3.Global Manufacturing Execution System in Life Sciences Market estimates & forecasts by Solution Type 2020-2030 (USD Billion)
TABLE 4.Global Manufacturing Execution System in Life Sciences Market estimates & forecasts by Deployment 2020-2030 (USD Billion)
TABLE 5.Global Manufacturing Execution System in Life Sciences Market estimates & forecasts by End-user 2020-2030 (USD Billion)
TABLE 6.Global Manufacturing Execution System in Life Sciences Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7.Global Manufacturing Execution System in Life Sciences Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8.Global Manufacturing Execution System in Life Sciences Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9.Global Manufacturing Execution System in Life Sciences Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10.Global Manufacturing Execution System in Life Sciences Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11.Global Manufacturing Execution System in Life Sciences Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12.Global Manufacturing Execution System in Life Sciences Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13.Global Manufacturing Execution System in Life Sciences Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14.Global Manufacturing Execution System in Life Sciences Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15.Global Manufacturing Execution System in Life Sciences Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16.U.S. Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17.U.S. Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18.U.S. Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19.Canada Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20.Canada Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21.Canada Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22.UK Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23.UK Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24.UK Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25.Germany Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26.Germany Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27.Germany Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28.France Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29.France Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30.France Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31.Italy Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32.Italy Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33.Italy Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34.Spain Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35.Spain Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36.Spain Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37.RoE Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38.RoE Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39.RoE Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40.China Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41.China Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42.China Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43.India Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44.India Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45.India Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46.Japan Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47.Japan Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48.Japan Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49.South Korea Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50.South Korea Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51.South Korea Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52.Australia Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53.Australia Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54.Australia Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55.RoAPAC Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56.RoAPAC Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57.RoAPAC Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58.Brazil Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59.Brazil Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60.Brazil Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61.Mexico Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62.Mexico Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63.Mexico Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64.RoLA Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65.RoLA Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66.RoLA Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67.Saudi Arabia Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68.South Africa Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69.RoMEA Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70.List of secondary sources, used in the study of Global Manufacturing Execution System in Life Sciences Market
TABLE 71.List of primary sources, used in the study of Global Manufacturing Execution System in Life Sciences Market
TABLE 72.Years considered for the study
TABLE 73.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1.Global Manufacturing Execution System in Life Sciences Market, research methodology
FIG 2.Global Manufacturing Execution System in Life Sciences Market, Market estimation techniques
FIG 3.Global Market size estimates & forecast methods
FIG 4.Global Manufacturing Execution System in Life Sciences Market, key trends 2022
FIG 5.Global Manufacturing Execution System in Life Sciences Market, growth prospects 2023-2030
FIG 6.Global Manufacturing Execution System in Life Sciences Market, porters 5 force model
FIG 7.Global Manufacturing Execution System in Life Sciences Market, pest analysis
FIG 8.Global Manufacturing Execution System in Life Sciences Market, value chain analysis
FIG 9.Global Manufacturing Execution System in Life Sciences Market by segment, 2020 & 2030 (USD Billion)
FIG 10.Global Manufacturing Execution System in Life Sciences Market by segment, 2020 & 2030 (USD Billion)
FIG 11.Global Manufacturing Execution System in Life Sciences Market by segment, 2020 & 2030 (USD Billion)
FIG 12.Global Manufacturing Execution System in Life Sciences Market by segment, 2020 & 2030 (USD Billion)
FIG 13.Global Manufacturing Execution System in Life Sciences Market by segment, 2020 & 2030 (USD Billion)
FIG 14.Global Manufacturing Execution System in Life Sciences Market, regional snapshot 2020 & 2030
FIG 15.North America Manufacturing Execution System in Life Sciences Market 2020 & 2030 (USD Billion)
FIG 16.Europe Manufacturing Execution System in Life Sciences Market 2020 & 2030 (USD Billion)
FIG 17.Asia Pacific Manufacturing Execution System in Life Sciences Market 2020 & 2030 (USD Billion)
FIG 18.Latin America Manufacturing Execution System in Life Sciences Market 2020 & 2030 (USD Billion)
FIG 19.Middle East & Africa Manufacturing Execution System in Life Sciences Market 2020 & 2030 (USD Billion)